Header Logo

Connection

Laurence Levine to Penile Induration

Back to Details
This is a "connection" page, showing publications Laurence Levine has written about Penile Induration.
Laurence Levine
Connection Strength
30.749
Penile Induration
  1. Predictors of hinge effect in patients with Peyronie's disease. J Sex Med. 2023 08 25; 20(9):1222-1227.
    View in: PubMed
    Score: 0.719
  2. Subcoronal inflatable penile prosthesis implantation: indications and outcomes. J Sex Med. 2023 05 26; 20(6):888-892.
    View in: PubMed
    Score: 0.706
  3. What's the new thing for surgical treatment of Peyronie's disease? Extratunical grafting. J Sex Med. 2023 03 31; 20(4):416-417.
    View in: PubMed
    Score: 0.699
  4. A Primer on the History of Intralesional Verapamil Injection for Peyronie's Disease. Urology. 2023 03; 173:5-7.
    View in: PubMed
    Score: 0.687
  5. Comparison of patient-reported outcomes after penile prosthesis placement in men with and without Peyronie's disease. Int J Impot Res. 2023 Sep; 35(6):569-576.
    View in: PubMed
    Score: 0.671
  6. Peyronie's disease: pharmacological treatments and limitations. Expert Rev Clin Pharmacol. 2021 Jun; 14(6):703-713.
    View in: PubMed
    Score: 0.608
  7. Peyronie's Disease and the Female Sexual Partner: A Comparison of the Male and Female Experience. J Sex Med. 2020 12; 17(12):2456-2461.
    View in: PubMed
    Score: 0.589
  8. Peyronie's disease: Contemporary evaluation and management. Int J Urol. 2020 Jun; 27(6):504-516.
    View in: PubMed
    Score: 0.568
  9. Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes. J Sex Med. 2020 05; 17(5):1005-1011.
    View in: PubMed
    Score: 0.564
  10. Long-term patient-reported outcomes in men with Peyronie's disease undergoing nonsurgical and nonintralesional injection management. Int J Impot Res. 2021 Jan; 33(1):75-81.
    View in: PubMed
    Score: 0.561
  11. Peyronie's Disease Intervention Studies: An Exploration of Modern-Era Challenges in Study Design and Evaluating Treatment Outcomes. J Sex Med. 2020 03; 17(3):364-377.
    View in: PubMed
    Score: 0.559
  12. Modern treatment strategies for penile prosthetics in Peyronie's disease: a contemporary clinical review. Asian J Androl. 2020 Jan-Feb; 22(1):51-59.
    View in: PubMed
    Score: 0.558
  13. The Surgical Treatment of Peyronie's Disease in the Older Man: Patient Characteristics and Surgical Outcomes in Men 65 and Older. J Sex Med. 2019 11; 16(11):1820-1826.
    View in: PubMed
    Score: 0.546
  14. Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease. Int J Impot Res. 2020 03; 32(2):257-258.
    View in: PubMed
    Score: 0.544
  15. Clinical characteristics and surgical outcomes in men undergoing tunica albuginea plication for congenital penile curvature who present with worsening penile deformity. World J Urol. 2020 Feb; 38(2):305-314.
    View in: PubMed
    Score: 0.534
  16. A Comparison of Hemostatic Patches Versus Pericardium Allograft for the Treatment of Complex Peyronie's Disease With Penile Prosthesis and Plaque Incision. Urology. 2019 07; 129:113-118.
    View in: PubMed
    Score: 0.529
  17. Nonsurgical management of Peyronie's disease. Nat Rev Urol. 2019 03; 16(3):172-186.
    View in: PubMed
    Score: 0.527
  18. The Penile Sensitivity Ratio: A Novel Application of Biothesiometry to Assess Changes in Penile Sensitivity. J Sex Med. 2019 03; 16(3):447-451.
    View in: PubMed
    Score: 0.525
  19. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study. BJU Int. 2019 04; 123(4):694-702.
    View in: PubMed
    Score: 0.517
  20. Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease. Int J Impot Res. 2019 Jan; 31(1):15-19.
    View in: PubMed
    Score: 0.507
  21. Devices for penile traction: the long and winding road to treating Peyronie's disease. Expert Rev Med Devices. 2018 08; 15(8):517-526.
    View in: PubMed
    Score: 0.505
  22. Surgical Outcomes of Plaque Excision and Grafting and Supplemental Tunica Albuginea Plication for Treatment of Peyronie's Disease With Severe Compound Curvature. J Sex Med. 2018 07; 15(7):1021-1029.
    View in: PubMed
    Score: 0.499
  23. Contemporary Review of Peyronie's Disease Treatment. Curr Urol Rep. 2018 May 17; 19(7):51.
    View in: PubMed
    Score: 0.499
  24. Surgical outcomes from limiting the use of nonabsorbable suture in tunica albuginea plication for Peyronie's disease. Int J Impot Res. 2017 Nov; 29(6):258-261.
    View in: PubMed
    Score: 0.474
  25. External Mechanical Devices and Vascular Surgery for Erectile Dysfunction. J Sex Med. 2016 11; 13(11):1579-1617.
    View in: PubMed
    Score: 0.448
  26. Contemporary Review of Treatment Options for Peyronie's Disease. Urology. 2016 Sep; 95:16-24.
    View in: PubMed
    Score: 0.427
  27. Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study. Int J Impot Res. 2016 Mar-Apr; 28(2):41-5.
    View in: PubMed
    Score: 0.422
  28. Examining Postoperative Outcomes after Employing a Surgical Algorithm for Management of Peyronie's Disease: A Single-Institution Retrospective Review. J Sex Med. 2015 Jun; 12(6):1474-80.
    View in: PubMed
    Score: 0.405
  29. Pharmacologic therapy for Peyronie's disease: what should we prescribe? Expert Opin Pharmacother. 2015 Jun; 16(9):1299-311.
    View in: PubMed
    Score: 0.404
  30. 2013-2014 updates in Peyronie's disease management. Curr Urol Rep. 2014 Dec; 15(12):459.
    View in: PubMed
    Score: 0.392
  31. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study. J Sex Med. 2015 Jan; 12(1):248-58.
    View in: PubMed
    Score: 0.391
  32. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment. J Sex Med. 2015 Jan; 12(1):259-64.
    View in: PubMed
    Score: 0.390
  33. Outcomes of surgical treatment of Peyronie's disease. BJU Int. 2014 May; 113(5):704-13.
    View in: PubMed
    Score: 0.377
  34. Peyronie's disease plaque calcification--prevalence, time to identification, and development of a new grading classification. J Sex Med. 2013 Dec; 10(12):3121-8.
    View in: PubMed
    Score: 0.362
  35. Peyronie's disease among men who have sex with men: characteristics, treatment, and psychosocial factors. J Sex Med. 2013 Aug; 10(8):2077-83.
    View in: PubMed
    Score: 0.352
  36. The clinical and psychosocial impact of Peyronie's disease. Am J Manag Care. 2013 03; 19(4 Suppl):S55-61.
    View in: PubMed
    Score: 0.347
  37. Standard operating procedures for Peyronie's disease. J Sex Med. 2013 Jan; 10(1):230-44.
    View in: PubMed
    Score: 0.342
  38. Surgery for Peyronie's disease. Asian J Androl. 2013 Jan; 15(1):27-34.
    View in: PubMed
    Score: 0.341
  39. A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: measured lengths and patient perceptions. J Sex Med. 2012 Sep; 9(9):2396-403.
    View in: PubMed
    Score: 0.335
  40. Is intralesional verapamil effective therapy for Peyronie's disease? J Urol. 2012 Sep; 188(3):704-6.
    View in: PubMed
    Score: 0.333
  41. Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease. J Urol. 2012 Jun; 187(6):2268-74.
    View in: PubMed
    Score: 0.327
  42. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. J Sex Med. 2012 Jan; 9(1):288-95.
    View in: PubMed
    Score: 0.316
  43. Predicting erectile dysfunction following surgical correction of Peyronie's disease without inflatable penile prosthesis placement: vascular assessment and preoperative risk factors. J Sex Med. 2012 Jan; 9(1):296-301.
    View in: PubMed
    Score: 0.314
  44. Review of non-surgical treatment options for Peyronie's disease. Int J Impot Res. 2012 Jan-Feb; 24(1):1-10.
    View in: PubMed
    Score: 0.314
  45. Partial plaque excision and grafting (PEG) for Peyronie's disease. J Sex Med. 2011 Jul; 8(7):1842-5.
    View in: PubMed
    Score: 0.310
  46. Current approach to the man with acute phase Peyronie's disease--case presentation and discussion. J Sex Med. 2011 Jun; 8(6):1556-8; quiz 1559.
    View in: PubMed
    Score: 0.308
  47. Peyronie's disease: review of nonsurgical treatment options. Urol Clin North Am. 2011 May; 38(2):195-205.
    View in: PubMed
    Score: 0.306
  48. Inflatable penile prosthesis placement in men with Peyronie's disease and drug-resistant erectile dysfunction: A single-center study. J Sex Med. 2010 Nov; 7(11):3775-83.
    View in: PubMed
    Score: 0.291
  49. The management of Peyronie's disease: evidence-based 2010 guidelines. J Sex Med. 2010 Jul; 7(7):2359-74.
    View in: PubMed
    Score: 0.286
  50. Penile shortening after radical prostatectomy and Peyronie's surgery. Curr Urol Rep. 2009 Nov; 10(6):468-74.
    View in: PubMed
    Score: 0.276
  51. Peyronie's disease: evaluation and review of nonsurgical therapy. ScientificWorldJournal. 2009 Jul 27; 9:665-75.
    View in: PubMed
    Score: 0.271
  52. Editorial comment on: Surgical treatment of Peyronie's disease by plaque incision and grafting with buccal mucosa. Eur Urol. 2009 Jun; 55(6):1475-6.
    View in: PubMed
    Score: 0.259
  53. Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow up. J Sex Med. 2008 Sep; 5(9):2221-8; discussion 2229-30.
    View in: PubMed
    Score: 0.252
  54. Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls. J Sex Med. 2008 Aug; 5(8):1977-84.
    View in: PubMed
    Score: 0.251
  55. FastSize Medical Extender for the treatment of Peyronie's disease. Expert Rev Med Devices. 2008 May; 5(3):305-10.
    View in: PubMed
    Score: 0.249
  56. Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie's plaque fibroblasts. J Urol. 2008 Jun; 179(6):2447-55.
    View in: PubMed
    Score: 0.248
  57. Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study. J Sex Med. 2008 Jun; 5(6):1468-73.
    View in: PubMed
    Score: 0.247
  58. Non-surgical therapy of Peyronie's disease. Asian J Androl. 2008 Jan; 10(1):79-87.
    View in: PubMed
    Score: 0.243
  59. Peyronie's Disease. Urol Clin North Am. 2007 Nov; 34(4):517-34, vi.
    View in: PubMed
    Score: 0.240
  60. The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman. J Sex Med. 2007 Sep; 4(5):1209-13.
    View in: PubMed
    Score: 0.237
  61. A Survey of primary-care physicians and urologists regarding Peyronie's disease. J Sex Med. 2007 Jul; 4(4 Pt 2):1167-73.
    View in: PubMed
    Score: 0.235
  62. Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study'. J Sex Med. 2007 Jul; 4(4 Pt 1):1081-2.
    View in: PubMed
    Score: 0.235
  63. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. J Urol. 2007 Mar; 177(3):972-5.
    View in: PubMed
    Score: 0.229
  64. Seeking answers on the quest for effective nonsurgical treatment of Peyronie's disease. Eur Urol. 2007 Mar; 51(3):601-3; discussion 603-4.
    View in: PubMed
    Score: 0.224
  65. Factors affecting the loss of length associated with tunica albuginea plication for correction of penile curvature. J Urol. 2006 Jan; 175(1):238-41.
    View in: PubMed
    Score: 0.211
  66. Peyronie's disease: etiology, epidemiology and medical treatment. Urol Clin North Am. 2005 Nov; 32(4):469-78, vii.
    View in: PubMed
    Score: 0.209
  67. Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction. J Sex Med. 2005 Mar; 2(2):241-7.
    View in: PubMed
    Score: 0.200
  68. Human cadaveric pericardial graft for the surgical correction of Peyronie's disease. J Urol. 2003 Dec; 170(6 Pt 1):2359-62.
    View in: PubMed
    Score: 0.183
  69. Establishing a standardized evaluation of the man with Peyronie's disease. Int J Impot Res. 2003 Oct; 15 Suppl 5:S103-12.
    View in: PubMed
    Score: 0.181
  70. Review of current nonsurgical management of Peyronie's disease. Int J Impot Res. 2003 Oct; 15 Suppl 5:S113-20.
    View in: PubMed
    Score: 0.181
  71. Peyronie disease in younger men: characteristics and treatment results. J Androl. 2003 Jan-Feb; 24(1):27-32.
    View in: PubMed
    Score: 0.172
  72. Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate. Int J Impot Res. 2002 Dec; 14(6):478-82.
    View in: PubMed
    Score: 0.171
  73. Intralesional verapamil for the treatment of Peyronie's disease: a review. Int J Impot Res. 2002 Oct; 14(5):324-8.
    View in: PubMed
    Score: 0.169
  74. A Consistent Lack of Consistency in Defining the Acute and Chronic Phases of Peyronie's Disease: A Review of the Contemporary Literature. Sex Med Rev. 2022 10; 10(4):698-713.
    View in: PubMed
    Score: 0.169
  75. A Consistent Lack of Consistency in Defining the Acute and Chronic Phases of Peyronie's Disease: A Review of the Contemporary Literature. Sex Med Rev. 2022 10 01; 10(4):698-713.
    View in: PubMed
    Score: 0.169
  76. Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol. 2002 Aug; 168(2):621-5; discussion 625-6.
    View in: PubMed
    Score: 0.167
  77. A Critical Analysis of Reporting in Systematic Reviews and Meta-Analyses in the Peyronie's Disease Literature. J Sex Med. 2022 04; 19(4):629-640.
    View in: PubMed
    Score: 0.162
  78. Surgical Correction of Adult Congenital Penile Curvature: A Systematic Review. J Sex Med. 2022 02; 19(2):364-376.
    View in: PubMed
    Score: 0.160
  79. Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. J Sex Med. 2021 02; 18(2):363-375.
    View in: PubMed
    Score: 0.150
  80. A Review of Treatment-Related Outcomes in Female Partners of Men With Peyronie's Disease-An Opportunity for Improved Assessment. Sex Med Rev. 2020 Oct; 8(4):548-560.
    View in: PubMed
    Score: 0.144
  81. A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie's disease. Int J Impot Res. 2000 Jun; 12(3):147-51.
    View in: PubMed
    Score: 0.144
  82. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature. Eur Urol. 2018 12; 74(6):767-781.
    View in: PubMed
    Score: 0.128
  83. Peyronie's disease: a difficult sexual dysfunction problem. West J Med. 1998 Sep; 169(3):168-9.
    View in: PubMed
    Score: 0.127
  84. Advances in the medical therapy of Peyronie's disease: a brief review. Int J Impot Res. 1998 Jun; 10(2):123-4.
    View in: PubMed
    Score: 0.125
  85. A Worldwide Survey on Peyronie's Disease Surgical Practice Patterns Among Surgeons. J Sex Med. 2018 04; 15(4):568-575.
    View in: PubMed
    Score: 0.123
  86. Grafts for Peyronie's disease: a comprehensive review. Andrology. 2018 Jan; 6(1):117-126.
    View in: PubMed
    Score: 0.121
  87. A surgical algorithm for the treatment of Peyronie's disease. J Urol. 1997 Dec; 158(6):2149-52.
    View in: PubMed
    Score: 0.121
  88. Treatment of Peyronie's disease with intralesional verapamil injection. J Urol. 1997 Oct; 158(4):1395-9.
    View in: PubMed
    Score: 0.119
  89. Penile vascular assessment using color duplex sonography in men with Peyronie's disease. J Urol. 1996 Apr; 155(4):1270-3.
    View in: PubMed
    Score: 0.108
  90. Peyronie's disease: urologist's knowledge base and practice patterns. Andrology. 2015 Mar; 3(2):260-4.
    View in: PubMed
    Score: 0.097
  91. Intralesional verapamil injection for the treatment of Peyronie's disease. J Urol. 1994 Jun; 151(6):1522-4.
    View in: PubMed
    Score: 0.095
  92. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease. J Sex Med. 2013 Nov; 10(11):2822-31.
    View in: PubMed
    Score: 0.090
  93. Traction therapy for men with shortened penis prior to penile prosthesis implantation: a pilot study. J Sex Med. 2011 Jul; 8(7):2112-7.
    View in: PubMed
    Score: 0.076
  94. Is there a place for conservative treatment in Peyronie's disease? J Sex Med. 2009 Apr; 6(4):903-909.
    View in: PubMed
    Score: 0.066
  95. Peyronie's disease. J Sex Med. 2004 Jul; 1(1):110-5.
    View in: PubMed
    Score: 0.048
  96. Tunica albuginea tissue analysis after electromotive drug administration. J Urol. 2003 May; 169(5):1775-8.
    View in: PubMed
    Score: 0.044
  97. Gene expression profiles in the Peyronie's disease plaque. Urology. 2002 Mar; 59(3):451-7.
    View in: PubMed
    Score: 0.041
  98. Symposium on Peyronie's disease April 12, 1997. Int J Impot Res. 1998 Jun; 10(2):121-2.
    View in: PubMed
    Score: 0.031
  99. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010 Nov; 7(11):3572-88.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.